TAXON was founded by scientists who were all affiliated with
CONICET. The rise of biotechnology companies has led to an explosion
in the amount of data generated from biological samples. This has
created a need for experts in bioinformatics, as well as
increased costs for specialized equipment and trained personnel.
The entrepreneurial team and founders of TAXON have extensive experience in conducting genomic comparative and identification studies, including sequencing, assembly, and analysis of bacterial and fungal isolates in various fields. This includes human health, where they have analyzed pathogenic strains such as E. faecium, B. cereus, B. anthracis, Acinetobacter baumannii, and Salmonella enterica, as well as probiotics such as Enterococcus mundtii, Lactobacillus paracasei, and Saccharomyces unisporum. They have also worked in industrial microbiology, analyzing strains such as Lactococcus lactis, L. cremoris, and L. lactis biovar. diacetylactis, and in the field of agricultural production, where they have analyzed strains such as B. safensis, B. pumilus, P. megaterium, and B. velezensis, among others.
From its inception, TAXON's vision has been to create new and better ways to generate value for biotechnology companies. By combining their expertise in molecular biology, genomics, and DNA-based analysis with the use of artificial intelligence (AI) for biological data analysis, TAXON is able to achieve results with greater accuracy and speed. This in turn creates value for companies by reducing analysis costs and times. Throughout its history, TAXON has continued to innovate and provide cutting-edge solutions to the biotechnology industry.
Work with us